What a Urology Patient Costs — and What a Dormant File Is Worth

Add the advertising spend, the agency or platform fees, the staff hours spent answering and scheduling, and the no-show rate. Divide by the patients who actually completed a visit — not the leads, not the calls. For most independent urology practices that lands somewhere between $150 and $600 per completed new-patient visit, and it climbs in competitive metros.

Every one of those dollars was spent to create a chart. When that chart goes quiet, the spend does not come back — it simply stops producing.

Reaching a former patient skips the expensive part of acquisition. There is no click to buy, no first-impression to earn, no insurance check from scratch. The remaining cost is a letter, a message, and a few minutes of front-desk time — typically a fraction of net-new acquisition for the same completed visit.

It also converts better. A patient with a documented PSA history or a lapsed surveillance interval has a concrete, personal reason to come back; a cold prospect has only your advertising.

Major surgery is modeled separately, with professional fees kept apart from facility reimbursement. These are planning ranges for an independent urology practice's opportunity analysis — not guaranteed reimbursement and not out-of-pocket prices.

Take the number of files inactive 18 months or more, assume a conservative 2–5% return a compliant 90-day sequence, and apply the planning range for the pathway mix you actually treat. For most practices that arithmetic lands somewhere between $80,000 and $150,000 of opportunity sitting untouched — which is why the list is worth pulling before you buy another click.